Open AccessRecommendations for the use of cladribine tablets for the pathogenetic treatment of patients with highly active multiple sclerosis
Author(s) -
K. Z. Bakhtiyarova,
Alexey Boyko,
Ya. V. Vlasov,
З. А. Гончарова,
M. V. Davydovskaya,
M. N. Zakharova,
Н. А. Малкова,
A. I. Nilov,
С А Сиверцева,
Н Н Спирин,
N. А. Totolyan,
Ф. А. Хабиров,
Maria Shumilina
Publication year - 2020
Publication title -
nevrologiâ, nejropsihiatriâ, psihosomatika
Language(s) - English
Resource type - Journals
eISSN - 2310-1342
pISSN - 2074-2711
DOI - 10.14412/2074-2711-2020-3-93-99
Subject(s) - cladribine , multiple sclerosis , exacerbation , medicine , drug , pharmacology , psychiatry